04/04/2023 -
This project was first launched in July 2021, when medical research charity The Scar Free Foundation launched a three-year, £2.5 million-plus regenerative research program at Swansea...
23/01/2023 -
Bioprinted from ‘rhCollagen,’ a plant-based alternative to human collagen, CollPlant’s implants are designed to promote cell regeneration, before gradually degrading into host...
16/11/2022 -
This year the winners are Photosynthetic (Netherlands), Lattice Medical (France), Rivelin Robotics (UK), SphereCube (Italy), and Alpha Powders (Poland). A further award, the AM Ventures Impact...
18/08/2022 -
BellaSeno’s 3D printed breast scaffolds are fully-resorbable, in that they’re designed to be implanted during breast regeneration, augmentation or revision surgeries, before being...
01/04/2022 -
Alongside the release of its FY 2021 results, which show that it generated $15.6 million in revenue, 155.7% more than the $6.1 million it reported in FY 2020, CollPlant announced that its...
24/02/2022 -
Currently undergoing preclinical trials, CollPlant’s bioprinted grafts are designed to degrade over time and be replaced by native tissues, in a treatment that could prove much safer than...
30/07/2021 -
Together with Yonsei University and LipoCoat, a Netherlands-based medical device coating company, Plcoskin will receive approximately 2B won ($1.7M) over the next three years. The funding will be...
02/02/2021 -
Unlike conventional replicas, the team’s novel silicone gonads can be 3D printed to match specific patient anatomies, making them a more comfortable and lifelike pelvic prosthetic....
13/11/2019 -
Leading German specialty chemicals business Evonik has signed a long-term agreement with 3D printed scaffold developer BellaSeno GmbH. The agreement guarantees BellaSeno’s use of...
06/09/2019 -
CollPlant, an Israeli 3D bioprinting and regenerative medicine firm, has announced that it is developing implants for breast tissue regeneration. After conducting early development, the company...